December 2, 2024 · Form 4 insider transaction
DSS, INC. sold 20 shares of IMPACT BIOMEDICAL INC at $2.90 per share, a transaction worth $58.00. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 112 days after the transaction.
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc.